Proposed code: BOD
Opening price: $0.245
Principal activities: Development of innovative biomedical devices
Corporate: Michael Bennett (CEO); Robert Towner (executive director); Robert Scott (non-executive director); and Caroline Bentley (company secretary).
(08) 9262 6777
Sponsoring broker: Bell Potter Securities Limited
© Business News 2018. You may share content using the tools provided but do not copy and redistribute.